Yanhui Liu

Title: The Innovative Journey of Yanhui Liu in Pharmaceutical Technology

Introduction

Yanhui Liu, a dedicated inventor based in Shanghai, China, has made significant strides in the field of pharmaceutical technology. His innovative work primarily focuses on developing compounds that address critical health issues. With his expertise, he has contributed a valuable patent that holds promise for various medical applications.

Latest Patents

Yanhui Liu holds a patent for "Matrine α-ketoamine compounds, preparation method therefor and use thereof." This invention presents a series of novel matrine α-ketoamine derivatives, aimed at inhibiting the overexpression of TNF-α and activating the immune killing function of NK cells. The potential applications of these derivatives include treating autoimmune diseases, inflammatory conditions, neurodegenerative disorders, and tumors stemming from abnormal TNF-α levels and NK cell dysfunction.

Career Highlights

Currently, Yanhui Liu is affiliated with Shanghai Xingye Pharmaceutical Technology Co., Ltd., where he continues to pursue his passion for innovation in the pharmaceutical sector. His work at this company plays a crucial role in developing new therapeutic methods that can benefit many patients suffering from diverse health issues.

Collaborations

In his professional journey, Yanhui Liu collaborates closely with his colleague Weibin Song. Together, they strive to push the boundaries of pharmaceutical research and innovation, aiming to create effective solutions for complex health problems.

Conclusion

Yanhui Liu's contributions to the field of pharmaceutical technology highlight the importance of innovation in addressing healthcare challenges. Through his patented work and collaborations, he continues to pave the way for advancements that could significantly impact the treatment of various diseases, reinforcing the vital role of inventors in improving global health outcomes.